Seer Inc. is a globally recognized data technology company that specializes in proteomics research. With its innovative approach and state-of-the-art technologies, Seer Inc. aims to revolutionize the field of life sciences by providing valuable insights into the human body’s complex proteome. Its Class A Common Stock offers investors an exciting opportunity to be a part of this groundbreaking journey.